Metastatic Colorectal Cancers Completed Phase 3 Trials for Fluorouracil (DB00544)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00252564Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal CancerTreatment
NCT01670721Colorectal Cancer MetastaticTreatment
NCT03288987A Clinical Trial to Evaluate the Efficacy and Safety of Bevacizumab (AryoGen Pharmed) Compared With Bevacizumab (Avastin®) in Metastatic Colorectal CancerTreatment
NCT00145314FLOX in Combination With Cetuximab in First-line Treatment of Colorectal CancerTreatment
NCT00399035Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal CancerTreatment
NCT00457691Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal CancerTreatment
NCT01219920FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal CancerTreatment